AlzeCure Publishes its Interim Report for January – September 2025
STOCKHOLM, SE / ACCESS Newswire / November 11, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) – AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January – September 2025 is now available on the company’s website: www.alzecurepharma.com/en/section/investors/financial-reports/ "The third quarter of 2025 was an active and eventful quarter for AlzeCure Pharma. […]